Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SafeScience initiates phase II trial for colorectal carcinoma drug candidate

June 8, 2000

Lexicon Genetics discovers gene controlling onset of aging, cancer in mice

June 8, 2000

Eos Biotechnology and Aventis Pasteur enter cancer vaccine agreement

June 7, 2000

ISIS-3521 to be advanced to phase III trials for NSCLC based on recent results

June 7, 2000

Arimidex receives Canadian approval for treatment of advanced breast cancer

June 7, 2000

Abarelix depot versus currently used therapies for prostate cancer: results of pivotal trials

June 7, 2000

ASGT presentation documents enhanced antitumor activity for p53 attached to VP22

June 7, 2000

ImClone Systems commences phase I trial of antiangiogenesis agent IMC-1C11

June 7, 2000

Compositions for radioimmunotherapy and diagnosis of tumors containing new chelating agents

June 6, 2000

CI-1042 (Onyx-015) extensively covered at ASCO meeting; preclinical and clinical results reported

June 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...